Both in Pharmaceuticals
Pfizer vs Merck & Co.
Over the past year PFE returned +23.8% and MRK returned +73.9%; their daily moves had a correlation of 0.45.
PFE +23.8% MRK +73.9%Growth of $1, one year, split-adjusted
| Metric | PFE | MRK |
|---|---|---|
| Price | $30.52 | $149.52 |
| Market cap | $173.95B | $368.89B |
| Today | +1.90% | +2.18% |
| 1 month | +8.5% | +4.0% |
| 6 months | +15.9% | +33.3% |
| Year to date | +22.6% | +42.0% |
| 1 year | +25.6% | +72.7% |
| Revenue growth (YoY) | +2.6% | +5.1% |
| Gross margin | 72.8% | 73.5% |
| Net margin | −1.6% | −8.0% |
| P/E (TTM) | 40.2× | 116.3× |
| Price / sales | 2.7× | 5.5× |
| Net cash | -$51.49B | -$46.77B |
| Dividend yield | 5.64% | 2.27% |
| Volatility (60d) | 19.8% | 36.0% |
| Short % of float | 2.4% | 1.1% |
| Next earnings | Nov 3, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).